-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TbINRgf3kWfUy16cnqTEcDinJO0MQ6+2zp9Pd7Upes3fTXOZqzL4hToDHXKlty09 /6vqumkXk5YbAO6qy7U+6A== 0001193125-08-099325.txt : 20080501 0001193125-08-099325.hdr.sgml : 20080501 20080501170109 ACCESSION NUMBER: 0001193125-08-099325 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080425 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20080501 DATE AS OF CHANGE: 20080501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CUTERA INC CENTRAL INDEX KEY: 0001162461 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770492262 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50644 FILM NUMBER: 08795473 BUSINESS ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 94005 MAIL ADDRESS: STREET 1: 3240 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: ALTUS MEDICAL INC DATE OF NAME CHANGE: 20011119 8-K 1 d8k.htm FORM 8-K Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

April 25, 2008

Date of Report (date of earliest event reported)

 

 

CUTERA, INC.

(Exact name of Registrant as specified in its charter)

 

Delaware   000-50644   77-0470324

(State or other jurisdiction of

incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

3240 Bayshore Blvd.

Brisbane, California 94005

(Address of principal executive offices)

(415) 657-5500

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Adjustments to Non-Employee Director Compensation

On April 25, 2008, our Compensation Committee (the “Committee”) of our Board of Directors (the “Board”) recommended to our Board, and our Board approved the 2008 annual equity and cash compensation for our non-employee directors, after a review of market trends and the changing level of responsibilities of our non-employee directors. The changes in cash compensation, effective from January 1, 2008, are as follows:

 

Annual Compensation (Paid Quarterly)

   Effective January 1, 2008(1)    Prior to Change

Board Member Fee

   $ 25,000    $ 25,000

Audit Committee Chair Fee

   $ 20,000    $ 17,000

Compensation Committee Chair Fee

   $ 20,000    $ 10,000

Audit Committee Member Fee

   $ 7,500    $ 6,500

Compensation Committee Member Fee

   $ 6,000    $ 4,000

 

(1) In addition to the annual compensation noted in this table, non-employee directors will each receive $1,000 for each meeting attended in a calendar year that exceeds seven regular board meetings, seven Audit Committee meetings and five Compensation Committee meetings. Prior to this change, those numbers were seven, nine and five, respectively.

In accordance with the terms of our 2004 Equity Incentive Plan, our Board approved changes in the equity compensation of our non-employee directors, effective January 1, 2008. Specifically, the initial grant of our stock options to new non-employee members of our Board was increased from 10,000 shares to 14,000 shares which shares shall continue to vest yearly over three years, subject to the director’s continuing service. Additionally, our Board adjusted the annual grant of our stock options to each of our non-employee directors from 5,000 shares to 7,000 shares. As a result, beginning with our annual meeting of stockholders in 2008 and immediately following each annual meeting thereafter, each non-employee director will be granted an option to purchase 7,000 shares of our common stock which will fully vest one-year after the grant date, subject to the director’s continuing service.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CUTERA, INC.

By:

  /s/ Kevin P. Connors
  Kevin P. Connors
  President and Chief Executive Officer

Date: May 1, 2008.

-----END PRIVACY-ENHANCED MESSAGE-----